| human | Q5 |
| P496 | ORCID iD | 0000-0002-7204-0058 |
| P1053 | ResearcherID | V-4734-2017 |
| P69 | educated at | University of Vienna | Q165980 |
| Medical University of Vienna | Q700731 | ||
| Medical University of Graz | Q872543 | ||
| P108 | employer | University Hospitals Salzburg | Q2496376 |
| Medical University of Graz | Q872543 | ||
| P734 | family name | Schallmoser | Q83380037 |
| Schallmoser | Q83380037 | ||
| Schallmoser | Q83380037 | ||
| P735 | given name | Katharina | Q16277712 |
| Katharina | Q16277712 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q38758704 | A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles. |
| Q53107971 | A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. |
| Q34046864 | A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells |
| Q43687671 | A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect. |
| Q36337390 | A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance. |
| Q51471250 | An alternative mini buffy coat preparation method for adult patients with extracorporeal photopheresis contraindications. |
| Q36422761 | Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q74341161 | C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease |
| Q38373823 | DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. |
| Q44370728 | Donor selection and release criteria of cellular therapy products. |
| Q34876718 | Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation |
| Q73434274 | Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease |
| Q43025180 | Function and activation state of platelets in vitro depend on apheresis modality. |
| Q46361829 | Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice |
| Q64059120 | Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues |
| Q45501605 | Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. |
| Q43222889 | Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. |
| Q91448111 | Human platelet lysate current standards and future developments |
| Q38631723 | Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? |
| Q37262399 | Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. |
| Q53540450 | Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. |
| Q59754893 | Identification of the Human Skeletal Stem Cell |
| Q80065302 | Immune cells mimic the morphology of endothelial progenitor colonies in vitro |
| Q84878975 | Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate |
| Q50513858 | Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function. |
| Q47409155 | International Forum on GMP-grade human platelet lysate for cell propagation. |
| Q47565005 | International Forum on GMP-grade human platelet lysate for cell propagation: summary. |
| Q50456872 | Iron depletion with a novel apheresis system in patients with hemochromatosis |
| Q48030147 | Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. |
| Q48257595 | Lesion-induced accumulation of platelets promotes survival of adult neural stem / progenitor cells |
| Q41034165 | Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use. |
| Q36270533 | Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate |
| Q27320392 | Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo |
| Q33415071 | Platelet antibody analysis by three different tests. |
| Q43204525 | Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. |
| Q38444449 | Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation. |
| Q92045054 | Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion |
| Q74028370 | Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria |
| Q46488249 | Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. |
| Q37723478 | Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance |
| Q40821352 | Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions |
| Q50519734 | Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. |
| Q52673002 | Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells. |
| Q33369106 | Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report. |
| Q33372491 | Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease |
| Q52842415 | Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation. |
| Q85837516 | T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy |
| Q81449788 | The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients |
| Q33383525 | The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia? |
| Q50476827 | Therapeutic red blood cell exchange in a child with sickle cell anaemia using the Spectra Optia® apheresis system. |
| Q33398627 | Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation. |
| Q50647997 | Thrombin generation before and after multicomponent blood collection. |
| Q39568332 | Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells. |
| Q80681229 | Two steps to functional mesenchymal stromal cells for clinical application |
| Q92332119 | Upregulation of mitotic bookmarking factors during enhanced proliferation of human stromal cells in human platelet lysate |
| Q78006163 | [Statins--attaining goal values--with reference to recent studies] |
Search more.